D.E. Shaw & Co’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5M Buy
470,270
+31,376
+7% +$317K ﹤0.01% 2175
2025
Q4
$4.12M Buy
438,894
+65,618
+18% +$514K ﹤0.01% 2469
2025
Q3
$2.81M Sell
373,276
-17,372
-4% -$87K ﹤0.01% 2714
2025
Q2
$1.32M Sell
390,648
-4,603
-1% -$17.2K ﹤0.01% 3044
2025
Q1
$1.53M Sell
395,251
-117,079
-23% -$559K ﹤0.01% 2805
2024
Q4
$3.16M Sell
512,330
-70,528
-12% -$408K ﹤0.01% 2355
2024
Q3
$3.14M Buy
582,858
+47,074
+9% +$221K ﹤0.01% 2343
2024
Q2
$1.79M Buy
535,784
+89,594
+20% +$349K ﹤0.01% 2745
2024
Q1
$1.8M Buy
446,190
+155,562
+54% +$415K ﹤0.01% 2717
2023
Q4
$770K Buy
290,628
+278,888
+2,376% +$639K ﹤0.01% 3303
2023
Q3
$27.7K Sell
11,740
-123,540
-91% -$576K ﹤0.01% 3957
2023
Q2
$852K Buy
135,280
+23,982
+22% +$147K ﹤0.01% 3174
2023
Q1
$642K Buy
+111,298
New +$832K ﹤0.01% 3429

Other funds holding DSGN